Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis

Antimicrobial Agents and Chemotherapy(2024)10.1128/aac.01584-23Source: DataRank Database

Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis is a research paper published in Antimicrobial Agents and Chemotherapy (2024). On theSindex it has a DataRank of 0. It has been cited 24 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access24 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:OA: hybridTopics (23)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Chris M. Pillar,Mariana Castanheira ORCID,Cecília G Carvalhaes ORCID,David R. Andes ORCID,Jalal A. Aram ORCID

Live enrichment

PubMed:38526046 PMC:PMC11064504

hybridLicense: cc-by

publisherhttps://doi.org/10.1128/aac.01584-23

publisherhttps://journals.asm.org/doi/pdf/10.1128/aac.01584-23

repositoryhttps://escholarship.org/content/qt0n7332gd/qt0n7332gd.pdf

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11064504/pdf/aac.01584-23.pdf

Unpaywallhttps://escholarship.org/uc/item/0n7332gd

MeSH Terms

HumansCandidaCandida albicansCandida glabrataCandida tropicalisAntifungal AgentsTreatment OutcomeMicrobial Sensitivity TestsAdultAgedMiddle AgedFemaleMaleEchinocandinsLipopeptidesCandidiasis, InvasiveCandidemiaCaspofungin

Keywords

CandidemiaCandida SpeciesAntifungal TherapyInvasive CandidiasisEchinocandin

Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis

FAIR Checklist

Authors (12)

Open Access

Topics

Annotations (Europe PMC)